ArticleInternational journal of cancer2023

FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision-making in real-world.

Norbert Marschner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.